tiprankstipranks
Trending News
More News >
aTyr Pharma (DE:471A)
FRANKFURT:471A
Germany Market
Advertisement

aTyr Pharma (471A) Technical Analysis

Compare
10 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
aTyr Pharma’s (471A) Moving Averages Convergence Divergence (MACD) indicator is -1.04, suggesting aTyr Pharma is a Buy.
aTyr Pharma’s (471A) 20-Day exponential moving average is 2.15, while aTyr Pharma’s (471A) share price is €0.68, making it a Sell.
aTyr Pharma’s (471A) 50-Day exponential moving average is 3.25, while aTyr Pharma’s (471A) share price is €0.68, making it a Sell.

aTyr Pharma (471A) Pivot Points

Sep 29, 2025, 10:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.70
0.71
0.71
0.72
0.72
0.73
0.73
Fibonacci
0.71
0.71
0.71
0.72
0.72
0.72
0.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

aTyr Pharma (471A) Moving Averages

Sep 29, 2025, 10:35 AM
Period
Simple
Exponential
MA5
0.69Sell
0.79Sell
MA10
0.78Sell
1.26Sell
MA20
2.72Sell
2.15Sell
MA50
3.80Sell
3.25Sell
MA100
3.97Sell
3.59Sell
MA200
3.62Sell
3.47Sell
aTyr Pharma’s (471A) 10-Day exponential moving average is 1.26, while aTyr Pharma’s (471A) share price is €0.68, making it a Sell.
aTyr Pharma’s (471A) 100-Day exponential moving average is 3.59, while aTyr Pharma’s (471A) share price is €0.68, making it a Sell.
aTyr Pharma’s (471A) stock price is €0.68 and aTyr Pharma’s (471A) 50-day simple moving average is 3.80, creating a Sell signal.
aTyr Pharma’s (471A) stock price is €0.68 and aTyr Pharma’s (471A) 100-day simple moving average is 3.97, creating a Sell signal.
aTyr Pharma’s (471A) stock price is €0.68 and aTyr Pharma’s (471A) 200-day simple moving average is 3.62, creating a Sell signal.

aTyr Pharma (471A) Technical Indicators

Sep 29, 2025, 10:35 AM
Name
Value
Implied Action
RSI (14)
24.98
Buy
STOCH (9,6)
9.75
Buy
STOCHRSI (14)
3.29
Buy
MACD (12,26)
-1.04
Buy
ADX (14)
33.30
Neutral
Williams %R
-98.21
Buy
CCI (14)
-75.76
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
36.40
Neutral
ROC
-85.39
Sell
aTyr Pharma’s (471A) Relative Strength Index (RSI) is 24.98, creating a Buy signal.
aTyr Pharma’s (471A) Trend Strength Indicator (ADX) is 33.30, creating a Neutral signal.
aTyr Pharma’s (471A) Commodity Channel Index (CCI) is -75.76, creating a Neutral signal.
aTyr Pharma’s (471A) Price Rate of Change (ROC) is -85.39, creating a Sell signal.

FAQ

Is 471A a Buy, Hold, or Sell?
Based on 471A’s technical indicators, 471A is a Sell.
    What is 471A’s RSI (14)?
    471A’s RSI (14) is 24.98, which suggests 471A is a Buy.
      What is 471A’s MACD?
      471A’s MACD is -1.04, which suggests 471A is a Buy.
        What is 471A’s 5-day moving average?
        471A’s 5-day moving average is 0.69, which suggests 471A is a Sell.
          What is 471A’s 20-day moving average?
          471A 20-day moving average is 2.72, which suggests 471A is a Sell.
            What is 471A’s 50-day moving average?
            471A’s 50-day moving average is 3.80, which suggests 471A is a Sell.
              What is 471A’s 200-day moving average?
              471A’s 200-day moving average is 3.62, which suggests 471A is a Sell.
                What is 471A’s Williams % R (14)?
                471A’s Williams % R (14) is -98.21, which suggests 471A is a Buy.
                  What is 471A’s CCI (14)?
                  471A’s CCI (14) is -75.76, which suggests 471A is a Neutral.
                    What is the share price of aTyr Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis